【FINTEC 0150 交流专区】（前名 ASIABIO）

icy97

icy97 发表于 27-1-2015 02:43 PM

亚洲生化 购油气物流失效

财经新闻 财经  2015-07-01 12:24
（吉隆坡30日讯）亚洲生化（ASIABIO，0150，创业板）宣布，与和隆集团（HoeLeong）和Reachmont物流，就收购两家油气物流公司所签署的暂定协议（HOA），在今日失效而且不会延长。

公司发文告宣布，不会延长与和隆集团和Reachmont物流签署的暂定协议。

根据文告，该协议在今日到期同时失效。

今年1月，亚洲生化宣布，将通过发行总值1.68亿令吉的股票，收购两家油气物流公司Semua船运和Semado海事，进军油气下游业。

配合收购计划，亚洲生化与幸马泰资源（SUMATEC，1201，主板贸服股）、和隆集团，以及Reachmont物流，签署暂定协议。

两家油气物流公司将被注入特别用途公司（SPV）；SPV的股东分别是和隆集团、Reachmont物流，以及Ebony Ritz公司。

亚洲生化将以发行总值1.68亿令吉的股票，收购SPV所有股权。【南洋网财经】

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ASIABIO" or "the Company")- STATUS UPDATE ON THE HEADS OF AGREEMENT IN RELATION TO THE PROPOSED ACQUISITION OF SEMUA SHIPPING SDN BHD ("SSSB") AND SEMADO MARITIME SDN BHD ("SMSB")
We refer to the Company’s announcements made on 27 January 2015, 31 March 2015, 27 April 2015, 28 April 2015 and 29 May 2015 respectively pertaining to the Heads of Agreement (“HOA”) entered into with Hoe Leong Corporation Ltd. (“HLCL”) and Reachmont Logistics Sdn. Bhd. (“RLSB”), the Board of Directors of Asiabio wishes to announce that the HOA will not be extended upon its expiration on 30 June 2015. Hence, the HOA shall be considered expired and lapsed on 30 June 2015. This announcement is dated 30 June 2015.

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ASIABIO" OR "THE COMPANY") - Termination of the Heads of Agreement in relation to the Proposed Acquisition of Semua Shipping Sdn. Bhd. ("SSSB") and Semado Maritime Sdn. Bhd. ("SMSB")
Further to the Company’s announcements made on 27 January 2015, 31 March 2015, 27 April 2015, 28 April 2015, 29 May 2015 and 30 June 2015 respectively pertaining to the Heads of Agreement (“HOA”) entered into with Hoe Leong Corporation Ltd. (“HLCL”) and Reachmont Logistics Sdn. Bhd. (“RLSB”) (collectively referred to as "Parties"), the Board of Directors of Asiabio wishes to further inform that as the Parties were not able to come to a mutual agreement on the terms and conditions stipulated in the HOA and accordingly, the Company had decided to terminate and let the HOA lapsed on 30 June 2015. This announcement is dated 3 July 2015.

icy97

亞洲生物能源私下售股籌1520萬

2015-07-09 10:51      
（吉隆坡8日訊）亞洲生物能源（ASIABIO，0150，創業板貿服組）建議私下配售最高佔總股本10%的新股；按每股10仙指標售價計，預計可募集介於866萬7千至1千520萬6千令吉資金，供科技孕育和營運資本用途。

引進新土著股東

該公司說，在創業板上市條例下，公司需符合至少佔總股本12.5%的土著持股需求，而公司已在今年4月要求國際貿工部審核現有土著股東架構，若貿工部最終認可的土著持股低於12.5%，公司將透過私下配售引進新土著股東。

不過，該公司補充即使土著持股最終符合要求，私下配售計劃也依然會繼續推行。（星洲日報／財經）

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	PROPOSED PRIVATE PLACEMENT
On behalf of the Board of Directors of Asia Bioenergy Technologies Berhad (“ABT”), TA Securities Holdings Berhad wishes to announce that the Company proposes to undertake the proposed private placement of new ordinary shares of RM0.10 each in ABT, representing not more than ten percent (10%) of the issued and paid-up share capital of ABT (excluding treasury shares, if any) (“Proposed Private Placement”). Please refer to the attachment for further details of the announcement. This announcement is dated 8 July 2015.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/4797453

Attachments ABT - Announcement (8 July 2015).pdf

icy97

SIA BRANDS BERHAD

EX-date	18 Sep 2015
Entitlement date	22 Sep 2015
Entitlement time	04:00 PM
Entitlement subject	Final Dividend
Entitlement description	Single Tier Tax Exempt Final Dividend of 0.5% per share
Period of interest payment	to
Financial Year End	31 Mar 2015
Share transfer book & register of members will be	22 Sep 2015   to   22 Sep 2015 closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no	SECURITIES SERVICES (HOLDINGS) SDN BHDLevel 7, Menara MileniumJalan Damanlela, Pusat Bandar DamansaraDamansara Heights50490 Kuala LumpurTel:0320849000Fax:0320949940
Payment date	13 Oct 2015
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	22 Sep 2015
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Percentage
Entitlement in Percentage (%)	0.5000
Par Value	Malaysian Ringgit (MYR)

icy97

Date of change	29 Jul 2015
Name	DATUK NUR JAZLAN BIN TAN SRI MOHAMED
Age	49
Nationality	Malaysia
Designation	Chairman
Directorate	Independent and Non Executive
Type of change	Resignation
Reason	To resign due to his appointment as Deputy Minister in the Government.

icy97

有兴趣投资再生能源 亚洲生化394万买宜鼎9.09%

财经新闻 财经  2015-08-07 10:08
（吉隆坡6日讯）亚洲生化（ASIABIO，0150，创业板）通过子公司Asiabio资本，以394万令吉认购宜鼎系统（AT，0072，创业板）9.09%股权。

亚洲生化昨天向马交所报备，Asiabio资本支付394万令吉，或每股10仙，认购宜鼎系统扩大股本后的9.09%股权，成为大股东之一。

据悉，宜鼎系统正在寻找资金来扩展业务，并瞄准手套和医疗领域，并在去年6月份进行私下配售。

亚洲生化指出，有兴趣投资在宜鼎系统正在进行的再生能源业务。

今年3月9日，宜鼎系统独资子公司AT工程解决方案私人有限公司（ATES），已从永续能源发展机构（SEDA）获得电力收购批准，以电力售价定在每千瓦69.77仙，以及介于5仙至17.22仙的额外售卖价格，售电给国家能源（TENAGA，5347，主板贸易服务股）。

亚洲生化相信，由于再生能源的需求不断增加，太阳能将成为最快增长的再生能源。

根据第10大马计划，政府今年目标，是今年总电力产量的5.5%或985兆瓦，源自于再生能源。【南洋网财经】

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR "THE COMPANY") - SUBSCRIPTION OF PLACEMENT SHARES IN AT SYSTEMIZATION BERHAD
1.         INTRODUCTION The Board of Directors of Asia Bioenergy Technologies Berhad (“ABT” or “the Company”) wishes to announce that its wholly-owned subsidiary, Asiabio Capital Sdn. Bhd. (“ACSB”) has on 5 August 2015 subscribed for AT Systemization Berhad (“ATS”) placement shares of 39,369,100 ordinary shares of par value RM0.10 each at an issue price of RM0.10 each (“Placement Shares”), representing 9.09% of the total enlarged issued and paid-up share capital of ATS for a total cash consideration sum of RM3,936,910 (“Consideration”) pursuant to ATS’s private placement exercise which was announced on 4 June 2014, 5 June 2014, 10 November 2014, 17 April 2015 and 27 July 2015 (“Subscription”). Subsequent to the subscription of the Placement Shares, ACSB will hold an aggregate of 9.09% equity shareholding in ATS’s enlarged issued and paid-up share capital. 2.         DETAILS OF THE SUBSCRIPTION 2.1       Information on ATS ATS is a public listed company listed on ACE Market of Bursa Malaysia Securities Berhad (“Bursa Securities”) with an authorised share capital of RM100,000,000, divided into 1,000,000,000 ordinary shares of RM0.10 each (“Shares”). Its enlarged issued and paid-up share capital upon completion of the Subscription will be RM43,306,063 comprising of 433,060,630 Shares. ATS, through its subsidiaries, designs and manufactures industrial automation systems and machinery, fabricates industrial and engineering parts, as well owns interests in dormant companies. ATS has on 10 March 2015 announced that its wholly owned subsidiary, AT Engineering Solution Sdn. Bhd. (ATES), had secured the Feed-in Approval (FiA) from Sustainable Energy Development Authority (“SEDA”) on 9 March 2015. ATES is expected to sign an agreement with Tenaga Nasional Berhad (“TNB”) for the sale and delivery of renewable energy by ATES to TNB for a concession period of 21 years.  SEDA has set a fixed rate-tariff of 69.77 sen per kWh and additional bonus rate-tariff ranging from five sen per kWh to 17.22 sen per kWh, at which ATES can sell electricity to TNB during the concession period, according to the announcement made. 2.2       Information of ACSB ACSB, which was incorporated on 28 November 2008, has an authorised share capital of RM10,000,000, divided into 10,000,000 ordinary shares of RM1.00 each, of which 6,021,000 are issued and fully paid up. ACSB’s principal activity is in investing and trading of quoted securities and related activities. 2.3       Basis of Arriving At the Consideration The Consideration was determined after the fixing of the issue price of RM0.10 per Placement Share on 27 July 2015 which represents a premium of approximately RM0.0056 or 5.93% from the five (5)-day weighted average market price of ATS shares up to and including 24 July 2015 of RM0.0944 per share. 2.4       Funding for the Subscription The Consideration paid for the Subscription was funded entirely from the technology incubator funds of the Company. 2.5       Liabilities to be Assumed There are no liabilities, including contingent liabilities and guarantees to be assumed by ABT, arising from the Subscription. 3.         RATIONALE ABT has investment interest in the business of renewable energy and this is currently being pursued by ATS which has an approval from  SEDA to supply renewable solar energy to TNB with its unit  ATES securing the Feed-in Approval (FiA) from SEDA to supply up to 425 kilowatts (kW) of renewable energy. ATES is expected to sign an agreement with TNB for the sale and delivery of renewable energy by ATES to TNB for a concession period of 21 years.  SEDA has set a fixed rate-tariff of 69.77 sen per kWh and additional bonus rate-tariff ranging from five sen per kWh to 17.22 sen per kWh, at which ATES can sell electricity to TNB during the concession period. ATES expects to build a 425kW solar power plant on its existing factory in Bayan Lepas, Penang, by December 2015 and estimates the plant would be able to generate RM11 million worth of renewable energy, over the concession period of 21 years. 4.         PROSPECTS ABT Group believes that solar power is set to become one of the most rapidly growing renewable energy sources in the world and its outlook will remain favorable in the long term future due to increasing demand for renewable energy which is further endorsed by the Malaysian government with the setting of a target for renewable energy to achieve 5.5% of Malaysia’s total electricity mix to be generated by 2015. 5.         RISK FACTORS Save for the normal business and global economic risk, the Board of Directors of ABT is not aware of any other risk factors which may arise as a result of the Subscription. 6.         FINANCIAL EFFECTS OF THE SUBSCRIPTION The Subscription is not expected to have any material effect on the earnings per share, net assets per share, gearing, share capital and the substantial shareholders' shareholdings of the ABT Group for the financial year ending 31 March 2016. 7.         APPROVALS REQUIRED The Subscription is not subject to any approvals being obtained by ABT. 8.         EXPECTED TIMEFRAME The Subscription is completed upon the quotation and listing of the Placement Shares on Bursa Securities on 5 August 2015. 9.         DIRECTORS’ AND MAJOR SHAREHOLDERS’ INTEREST None of the Directors and/or major shareholders and/or any person connected to the Directors and/or major shareholders of ABT has any interest, either direct or indirect in ATS. 10.       DIRECTORS’ STATEMENT The Board of Directors of ABT having considered all aspects of the Subscription is of the opinion that the Subscription is in the best interest of the ABT Group. 11.       PERCENTAGE RATIO The highest percentage ratio applicable to the Subscription pursuant to Rule 10.02 of the Listing Requirements of Bursa Malaysia Securities Berhad for the ACE Market is 6.12% based on the latest audited financial statements of ABT as at 31 March 2015 and ATS as at 28 February 2015. This announcement is dated 5 August 2015.

icy97

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-06082015-00001
Subject	SUBSCRIPTION OF PLACEMENT SHARES IN AT SYSTEMATIZATION BERHAD ("ATS").
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR "THE COMPANY") - SUBSCRIPTION OF PLACEMENT SHARES IN AT SYSTEMIZATION BERHAD
We refer to the Company's announcement dated 5 August 2015 and the query letter dated 6 August 2015 from Bursa Malaysia Securities Berhad. The Board of Directors of the Company wishes to further inform that:- a)         ABT’s wholly-owned subsidiary, Asiabio Capital Sdn. Bhd. (“ACSB”) has on 3 August 2015 subscribed for AT Systemization Berhad (“ATS”) placement shares of 39,369,100 ordinary shares of par value RM0.10 each at an issue price of RM0.10 each (“Placement Shares”), representing 9.09% of the total enlarged issued and paid-up share capital of ATS for a total cash consideration sum of RM3,936,910 (“Consideration”). The Consideration sum of RM3,936,910 was paid on 31 July 2015. b)         Based on the latest audited financial statements for the financial year ended 28 February 2015 of ATS, the Net Profit attributable to owner of ATS and its Net Assets were RM712,688 and RM41,450,194 respectively. (c)        The estimated value of renewable energy generated by AT Engineering Solution Sdn. Bhd. (“ATES”)’s plant of approximately RM11 million over a period of 21 years is based on the fixed rate-tariff of RM0.6977/kWh and additional bonus rate-tariff of RM0.1722/kWh on the assumption that the bonus criteria are met, with a 425kW installed capacity covering the said period. This announcement is dated 6 August 2015.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2015

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2015	30 Jun 2014	30 Jun 2015	30 Jun 2014
		$$'000	$$'000	$$'000	$$'000

1	Revenue	6,474	0	6,474	0
2	Profit/(loss) before tax	-10,270	0	-10,270	0
3	Profit/(loss) for the period	-10,270	0	-10,270	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	-10,182	0	-10,182	0
5	Basic earnings/(loss) per share (Subunit)	-1.17	0.00	-1.17	0.00
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0625		0.0742

icy97

亞洲生物能源 擬削面值抵消4562萬虧損

財經28 Oct 2015 23:00
（吉隆坡28日訊）亞洲生物能源（ASIABIO，0150，創業板貿服）建議透過削減面值，從每股10仙削減至每股5仙，以抵消總值4562萬令吉的累計虧損。

馬證交所報備文件指出，冀透過削減面值抵消截至2015財年3月31日的累計虧損2250萬8000令吉，及截至6月30日的累計虧損2310萬8000令吉，總值4561萬6000令吉。

該公司指出，削減面值所得用以抵消總值4562萬令吉的累計虧損后，或有介于4105萬6000令吉至1億644萬令吉的保留盈余（retained earnings）。

報備文件指出，是項面值削減將涉及憑單行使，若完成后，該公司新的繳足資本最少也有8億6671萬1600股或值4333萬5580令吉，最多則可達15億2061萬3400股或相等于7603萬670令吉。

該公司希望在完成削減面值后，可消除虧損之余，亦可合理化財務報表；是項建議仍需獲得股東批准。【中国报财经】

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR THE "COMPANY")REDUCTION OF THE ISSUED AND PAID-UP SHARE CAPITAL OF THE COMPANY PURSUANT TO SECTION 64(1) OF THE COMPANIES ACT, 1965 INVOLVING THE CANCELLATION OF RM0.05 OF THE EXISTING PAR VALUE OF THE ORDINARY SHARE OF RM0.10 EACH IN ABT TO RM0.05 EACH IN ABT ("PROPOSED PAR VALUE REDUCTION")
On behalf of the Board of Directors of ABT, TA Securities Holdings Berhad (“TA Securities”) wishes to announce that the Company proposes to undertake the Proposed Par Value Reduction. Please refer to the attachment for further details of the Proposed Par Value Reduction. This announcement is dated 28 October 2015.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/4905045

Attachments ABT - Announcement (28 Oct 2015).pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2015

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2015	30 Sep 2014	30 Sep 2015	30 Sep 2014
		$$'000	$$'000	$$'000	$$'000

1	Revenue	10	0	6,484	0
2	Profit/(loss) before tax	-15,219	0	-25,489	0
3	Profit/(loss) for the period	-15,219	0	-25,489	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	-15,134	0	-25,316	0
5	Basic earnings/(loss) per share (Subunit)	-1.75	0.00	-2.92	0.00
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0521		0.0742

icy97

[tr][/tr]

Date of change	02 Dec 2015
Name	DATO' SERI ABDUL AZIM BIN MOHD ZABIDI
Age	56
Nationality	Malaysia
Designation	Chairman
Directorate	Independent and Non Executive
Type of change	Appointment
Qualifications	1. Master of Arts in Business Law from London Metropolitan University, United Kingdom; and2. Fellow Member of the Institute of Chartered Secretaries and Administrators.
Working experience and occupation	Dato' Seri Abdul Azim Bin Mohd Zabidi was a Chairman of Bank Simpanan Nasional ("BSN"), a Malaysia's National Savings Bank. Growing from his work with BSN, Dato' Seri Abdul Azim was also active in the work undertaken by the Brussels based World Savings Banks Institute ("WSBI"). In year 2000, he was appointed as President (Asia Pacific) for WSBI and in year 2003, he was elevated to its Board of Directors. In addition, he was elected as Vice President and Treasurer of WSBI from September 2006 until April 2009.A long association with the unit trusts/mutual funds and fund management industry culminated in his election as President of the Federation of Malaysian Unit Trust Managers, a post held from year 1998 to year 2003. During this period, he was appointed as Member of the Steering Committee of the International Investment Funds Association ("IIFA"), Montreal, Canada, a post held by him until 2008. From year 2007 to year 2008,  he was elected as a member of the Board of Directors and Chairman of the Audit Committee of IIFA.Dato' Seri Abdul Azim has served in numerous capacities at all levels of the United Malays National Organisation ("UMNO"), the senior party in the coalition that has ruled Malaysia since Independence in 1957. In year 2004, he was appointed as the party's Treasurer by the former Prime Minister and UMNO President, Tun Abdullah Ahmad Badawi. He was also designated Treasurer General of Barisan Nasional, or National Front, Malaysia's multi-ethnic ruling coalition. Earlier, he was elected to UMNO's Supreme Council in year 2000.He was also a member of the National Economic Consultative Council II, where he served on the Islamic Banking and Finance Committee. He was also selected by the Securities Commission to be a member of its Capital Market Advisory Council. He was invited by Bursa Malaysia Berhad to be a member of its Index Committee and Deputy Chairman of its Board of Advisors for the Malaysian Central Depository.
Directorship of public companies (if any)	1. XOX Berhad; 2. Wang-Zheng Berhad; 3. Timberwell Berhad; and4. Anzo Holdings Berhad

tsm33

嗲到剩0.045了

哭哭鸟

0150    ASIABIO    ASIA BIOENERGY TECH BHD

Quarterly rpt on consolidated results for the financial period ended 31/12/2015

Quarter: 3rd Quarter Financial Year End: 31/03/2016 Report Status: Unaudited Submitted By: Current Year Quarter Preceding Year Corresponding Quarter Current Year to Date Preceding Year Corresponding Period 31/12/2015 31/12/2014 31/12/2015 31/12/2014 RM '000 RM '000 RM '000 RM '000 1 Revenue 91 0 6,575 0 2 Profit/Loss Before Tax 7,076 0 (18,413) 0 3 Profit/Loss After Tax and Minority Interest 7,156 0 (18,160) 0 4 Net Profit/Loss For The Period 7,076 0 (18,413) 0 5 Basic Earnings/Loss Per Shares (sen) 0.83 0.00 (2.10) 0.00 6 Dividend Per Share (sen) 0.00 0.00 0.00 0.00 As At End of Current Quarter As At Preceding Financial Year End 7 Net Assets Per Share (RM) 0.0603 0.0742

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	PROPOSED PRIVATE PLACEMENT
Reference is made to the Company’s announcements dated 8 July 2015, 9 July 2015 and 19 February 2016 in relation to the Proposed Private Placement and announcement dated 17 February 2016 in relation to the Bumiputera equity condition (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. Please refer to the attachment for the details of the revised utilisation of proceeds. This announcement is dated 11 March 2016.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5027701

Attachments Revised utilisation.pdf

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	PROPOSED PRIVATE PLACEMENT
Reference is made to the Company’s announcements dated 8 July 2015, 9 July 2015, 19 February 2016 and 11 March 2016 in relation to the Proposed Private Placement (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. On behalf of the Board, TA Securities wishes to provide additional information in relation to the Proposed Private Placement. Please refer to the attachment for further details. This announcement is dated 7 April 2016.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5052749

Attachments Announcement - Further Information.pdf

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR THE "COMPANY")PRIVATE PLACEMENT OF UP TO TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF ABT ("PRIVATE PLACEMENT")
Reference is made to the Company’s announcements dated 8 July 2015, 9 July 2015, 19 February 2016, 11 March 2016, 7 April 2016 and 8 April 2016 in relation to the Private Placement (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. On behalf of the Board, TA Securities wishes to announce that the Board has on 23 May 2016 fixed the issue price for 86,671,000 Placement Shares at RM0.05 each. This issue price represents a premium of approximately 24.38% to the five (5)-day volume weighted average market price of the ABT Shares up to and including 20 May 2016 of RM0.0402. This announcement is dated 23 May 2016.

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR THE "COMPANY")PRIVATE PLACEMENT OF UP TO TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF ABT ("PRIVATE PLACEMENT")
Reference is made to the Company’s announcements dated 8 July 2015, 9 July 2015, 19 February 2016, 11 March 2016, 7 April 2016, 8 April 2016 and 23 May 2016 in relation to the Private Placement (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. On 23 May 2016, the Board fixed the issue price for 86,671,000 Placement Shares at RM0.05 each. Pursuant to Rule 6.14 of the Listing Requirements, the payment for the Placement Shares must be made by the placees within five (5) market days from the price-fixing date (i.e., by 30 May 2016). As the payment for the 86,671,000 Placement Shares has not been received as at today, the Board has decided to re-fix the issue price today for the 86,671,000 Placement Shares at RM0.05 each. This issue price represents a premium of approximately 24.69% to the five (5)-day volume weighted average market price of ABT Shares up to and including 27 May 2016 of RM0.0401. This announcement is dated 30 May 2016.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2016	31 Mar 2015	31 Mar 2016	31 Mar 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	2,943	0	9,518	0
2	Profit/(loss) before tax	-10,415	0	-28,828	0
3	Profit/(loss) for the period	-10,415	0	-28,828	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	-9,272	0	-27,432	0
5	Basic earnings/(loss) per share (Subunit)	-1.07	0.00	-3.17	0.00
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0461		0.0742

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	PRIVATE PLACEMENT OF UP TO TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF ASIA BIOENERGY TECHNOLOGIES BERHAD ("PRIVATE PLACEMENT")
No. of shares issued under this corporate proposal	86,671,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0500
Par Value ($$)	Malaysian Ringgit (MYR)   0.050
Latest issued and paid up share capital after the above corporate proposal in the following
Units	953,382,600
Currency	Malaysian Ringgit (MYR) 47,669,130.000
Listing Date	01 Jun 2016

icy97

仍看好前景．亚洲生物能源续投资油气下游业

（吉隆坡24日讯）亚洲生物能源（ASIABIO，0150，创业板贸服组）相信油气领域将好转，因此不放弃投资在油气下游领域的计划。

亚洲生物能源执行董事陈石义在股东大会后表示，该公司瞄准的是可以提供附加价值和服务的油气公司。

他相信大马油气业依然拥有作为，并会好转。

他说，该公司目前有一些计划在进行，惟尚不能公布详情。

他也指出，该公司目前没有投资在其他领域的计划。

陈石义说，亚洲生物能源在2016财政年面对亏损，主要是因为全球经济不明朗，导致投资情绪低迷，拖累公司所投资的上市公司股价下滑。

亚洲生物能源2016财政年净亏损由前期的377万4674令吉扩大至2743万1801令吉；营业额则由前期的5323万2689令吉缩减至951万8186令吉。

该公司也更换财政年结账日期至3月31日。

投资对象基本面强劲

另一位执行董事梁国强说，该公司所投资的上市公司基本面都很强劲。

“威能（VSOLAR，0066，创业板科技组）专注在太阳能项目、富斯科（FOCUS，0116，创业板科技组）业务则涉及餐饮业和NETX控股（NETX，0020，创业板科技组）则涉及支付系统。”

他说，公司目前所要做的事情是采取积极措施打造公司。

他说，在近年，该公司改变投资策略，投资在上市公司，以便可以了解所投资的公司运作。

梁国强目前是威能和富斯科的执行董事，陈石义则是NETX的执行董事。

陈石义认为，该公司的投资属于长期性投资，因此，需时至少3至4年的时间始能看到成功。

另外，提到与威能合作在太阳能发电站种植农作物一事，梁国强表示该站建设已完成，预计将于今年9月运作。

他说，亚洲生物能源希望通过微生物协助该站取得更有效的增长。

他说，该公司的研发部门在研究可种植在该站的农作物。

文章来源：
星洲日报‧财经‧2016.08.24